Chemical industry – Page 74
-
Business
Drax pulls out of carbon capture power station plans
Energy giant says government policies have slashed income and made carbon capture project too costly
-
OpinionSpice up your compounds
An occasional foray into uncharted territory is the hot sauce of medicinal chemistry, says Derek Lowe
-
BusinessBayer CropScience pays $5.6m to settle 2008 accident charges
Fine will fund environmental projects, fire department upgrades and wastewater treatment facilities
-
BusinessCosmetics deals push skin 3D bioprinting
Interest for testing from L’Oréal, BASF and Procter & Gamble could be a stepping stone towards bespoke organs
-
Business
Amgen expands cardiovascular portfolio with Dezima acquisition
Amgen’s $300 million purchase of Dutch biotech gives the company the potential to offer more varied treatment options to lower cholesterol
-
BusinessMerger fever sweeps pharma
The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?
-
Business
Syngenta to sell off seed business after failed Monsanto takeover
Syngenta to restore shareholder confidence following a series of failed takeover bids by Monsanto
-
Business
Cancer Drugs Fund axes 23 treatments
The UK government has cut down the list of cancer therapies it will pay for through the Cancer Drugs Fund
-
BusinessUS regulator reprimands Cepheid for norovirus diagnosis tool quality
Diagnostics firm has 15 days to respond to violations laid out by regulator
-
Business
Novartis to buy experimental MS drug from GSK in $1bn deal
Deal will help to bolster Novartis’s pipeline for neurological disorder treatments
-
Business
FDA takes action to remove biosimilars roadblock
The US Food and Drug Administration proposes system to name biosimilar drugs
-
OpinionA risky business
Graduate research is likely the most risky time of a chemist’s career, says Derek Lowe
-
Opinion
Drugs in a class of their own
New drug types need careful regulation to reward innovation while protecting patients
-
Business
Syngenta fends off Monsanto takeover bid
Unmoving objection to merger leads US giant to drop pursuit
-
BusinessFemale sexual desire drug approved
Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions
-
BusinessIndian pharma under increased regulatory scrutiny
Import bans and tightened rules pose a significant challenge for companies
-
BusinessPorous pills could be largest industrial 3D printing use
US grants first-of-a-kind approval for Aprecia’s epilepsy tablets exploiting porous structure
-
BusinessGreek crisis puts pressure on pharmaceuticals
Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece
-
BusinessNo one should be denied medication
Exclusive interview with Yusuf Hamied, chairman of Indian generic drugmaker Cipla